Youre losing fat, youre losing tissue integrity, and all those things matter for a healthy pelvic floor. How GLP-1 usage impacts women's health Vaginal changes from GLP-1 use can include decreased lubrication, vaginal dryness, loss of pelvic floor strength, and symptoms associated with a weakened pelvic floor, such as bladder leakage and painful sex
Avoid stopping levothyroxine or semaglutide without guidance, and never adjust thyroid medication doses on your own
The FDA-approved formulations for weight loss are semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound)
Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson's disease
Osteoporos Int 36 , 21152126 (2025)
Phase 3 trials are ongoing and definitive cardiovascular conclusions cannot yet be drawn